Form 4: Carlyle Group Continues to Trim Stake in QuidelOrtho Corp (QDEL) Through 10b5-1 Trading Plan

The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock between June 18 and June 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group, along with related entities, has reported the sale of QuidelOrtho Corp (QDEL) common stock.
• These transactions occurred between June 18 and June 20, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On June 18, 2024, 31,730 shares were sold at a weighted average price of $35.7402, and 16,811 shares were sold at a weighted average price of $36.3791.
• On June 20, 2024, 49,593 shares were sold at a weighted average price of $34.8158, and 17,614 shares were sold at a weighted average price of $35.0856.
• Following these transactions, the Carlyle Group's indirect beneficial ownership stands at 11,908,315 shares.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
• The Carlyle Group Inc. and several related entities may be deemed to share beneficial ownership but disclaim such ownership.

Sentiment

Score: 5

Explanation: The document simply reports transactions. It's neutral from an investment perspective unless further sales are anticipated to negatively impact the stock price.

Risks

• Continued sales by the Carlyle Group could exert downward pressure on QDEL's stock price.

Future Outlook

The Carlyle Group may continue to sell shares of QuidelOrtho under the existing 10b5-1 trading plan.

Industry Context

Private equity firms like Carlyle often reduce their stakes in portfolio companies over time to realize returns for their investors. This sale is a continuation of that trend.

Stakeholder Impact

• Shareholders may experience short-term price fluctuations due to the sale of shares.
• The company may experience a slight decrease in institutional ownership.

Key Dates